Acquisition
Lundbeck Strengthens Neuro-Rare Disease Portfolio with $2.6 Billion Acquisition of Longboard Pharmaceuticals
Lundbeck, Longboard Pharmaceuticals, Neuro-Rare Diseases, Acquisition, Biotech, Pharmaceutical Industry
Grünenthal Acquires US-Based Valinor Pharma for $250 Million
Grünenthal, Valinor Pharma, acquisition, Movantik, naloxegol, opioid-induced constipation, pain management, US market expansion, pharmaceutical industry